Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Nicholson Science Pheromone Trial for Opioid Addiction
NCT03394911Phase 3Unknown
- Sponsor
- Bubba Nicholson
- Start
- Dec 2020
- Primary completion
- Nov 2021
01
Overview
Phase 3, randomised, double-blind trial in opioid use disorder (OUD) (2 arms), sponsored by Bubba Nicholson. Primary endpoints: Clean Tox Screen, UDS, urinary drug screen at 6 weeks and Dirty Tox Screen at 6 weeks. Status: unknown.
02
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT03394911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03394911.